Treatment of virus infections with ganglionic blocking agents

Details Treatment of virus infections with ganglionic blocking agents Treatment of virus infections with ganglionic blocking agents

1995-06-07

1997-11-11

Travers, Russell

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514416, 514431, 514443, 514422, 514642, A61K 3155, A61K 3140, A61K 4302, A61K 3138

Patent

active

056864485

ABSTRACT:
A method for preventing or treating infection or disease in a mammal caused by a virus, such as herpes simplex virus type 1 and 2. A ganglionic blocking agent, such as tetraethylammonium ion or hexamethonium ions, is administered to the mammal in an effective dosage.

REFERENCES:
patent: 5158980 (1992-10-01), Baldone
Kozlov et al, 1980, Vests: Akad. Navak BSSR, Sec. Khim. Neurle vol. 5 pp. 84-86.
Kozlov, N.S. et al., Synthesis and Antiviral Activity of Salts of Tetrasubstituted Ammonium, Chem. Abstracts, 94:24805 (1981).

Affiliated with

Also associated with

Rating

Treatment of virus infections with ganglionic blocking agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of virus infections with ganglionic blocking agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of virus infections with ganglionic blocking agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1229340